Jefferies


Is It Premature to Celebrate Gilead Sciences, Inc.’s (GILD) Kite Pharma Momentum? Jefferies Looks Beyond the Recent Bull Rally

Analyst questions the bigger picture for GILD, including risks and visibility challenges wavering in 2018.

Top Analyst’s Internet Stock Picks: Facebook Inc (FB) and Amazon.com, Inc. (AMZN)

Here’s Why Facebook and Amazon Are Long-Term Winners of the Wall Street Horse Race

Will Trade Desk Inc (TTD) Momentum Continue? Top Analyst Says Yes

Trade Desk Inc (NASDAQ:TTD) stock is ticking upward today, after the digital ad firm delivered another beat and raise quarter, driven by sustained …

Jefferies Sees Strong Upside in AcelRx Pharmaceuticals’ Shares and Set a $7 Price Target

In a research report issued Friday, Jefferies analyst Matthew Andrews assumed coverage on shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), with a Buy rating and a $7.00 price …

Snap Inc (SNAP) Poised for Upside Ahead of 1st Quarter as a Public Company

Jefferies analyst Brian Fitzgerald is out with a confident research note evaluating Snap Inc (NYSE:SNAP) today, specifically commending the popular Snapchat app parent company’s …

What to Expect from Gilead Sciences, Inc. (GILD) Amid M&A Buzz and Upcoming Catalysts

Analysts see an interesting path ahead for Gilead Sciences, Inc. (NASDAQ:GILD), between exciting collaborative possibilities and its pipeline catalysts that have brought bullish …

Jefferies’ Brian Fitzgerald Reacts To Facebook Inc (FB) And Shutterfly, Inc. (SFLY) 4Q Prints

Jefferies analyst Brian Fitzgerald is joining the earnings conversation with mixed takes on Facebook Inc (NASDAQ:FB) and Shutterfly, Inc. (NASDAQ:SFLY).

Jefferies’ Earnings Preview: Facebook Inc (FB), Amazon.com, Inc. (AMZN), Alphabet Inc (GOOGL)

Previewing fourth-quarter earnings, Jefferies analyst Brian Fitzgerald is setting confident expectations on the following large-cap internet stocks in his coverage: Facebook Inc (NASDAQ:FB), Amazon.com, …

Jefferies Says Buy Alphabet Inc (GOOGL); Here’s Why

Jefferies analyst Brian Fitzgerald has reiterated his Buy rating for Alphabet Inc (NASDAQ:GOOGL) following yesterday’s reveal that the tech giant and Honda are in …

Hold Your Horses: Healthcare Analysts Cautious on Valeant Pharmaceuticals Intl Inc (VRX), Sarepta Therapeutics Inc (SRPT)

Valeant Pharmaceuticals Intl Inc Wells Fargo analyst David Maris weighs in on shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), as the drug maker focuses …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts